Interleukin-10 is produced during incubation of human whole blood with
bacterial lipopolysaccharide (LPS) and down-regulates tumour necrosis
factor-alpha production in this in-vitro model of endotoxaemia. 39 ou
t of 69 (57%) patients with gram-negative (n = 25) or gram-positive se
pticaemia (n = 44) had increased plasma interleukin-10 (range 12-2740
pg/mL), whereas interleukin-10 was undetectable in 29 out of 33 contro
l patients without infection and in 20 healthy volunteers. Patients wi
th septic shock (n = 21) had higher interleukin-10 (median 58 pg/mL) t
han septicaemic patients without shock (11 pg/mL, p<0.001). We conclud
e that interleukin-10 is produced during sepsis and might be involved
in the control of the inflammatory response induced by bacterial produ
cts.